FMP
SynBiotic SE
SBX.DE
XETRA
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.
9.86 EUR
0.8 (8.11%)
About
ceo
Mr. Lars Muller
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.synbiotic.com
exchange
XETRA
Description
SynBiotic SE engages in the development of medicines and over-the-counter wellness products based on cannabinoids. It focuses on synthetic production of cannabinoids, drug development, nutritional supplements, and cosmetic products. The company was formerly known as Ledgertech SE and changed its name to Ledgertech SE. SynBiotic SE based in Munich, Germany.
CIK
N/A
ISIN
DE000A3E5A59
CUSIP
N/A
Address
Innere Wiener Str. 14
Phone
49 89 6003 7544
Country
DE
Employee
104
IPO Date
Jan 7, 2021
Key Executives
